While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

Coverage of GLP-1s is not necessarily in-your-face obvious. It leads to the conversation of whether we want to pursue weight ...

Drugs like Ozempic have a positive impact on weight loss, though only for a short period, with long-term health implications ...

The GLP-1 weight loss market is a massive one, with some analysts expecting it to be worth around $200 billion by 2031. Hype around weight loss drugs isn't new, but when people are losing more ...

Social support can improve the odds of successful weight loss. AnnaLee Canario and Dacia Benjamin say their friendship is the ...

The news has been littered with stories these days about people losing weight using GLP-1 weight loss drugs like Ozempic. Now ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about Ozempic's and Mounjarno's patent cliffs. The scenarios in which Novo ...

Guo and co-authors found no evidence of significant interaction in a subgroup analysis stratified by age, sex, race and ethnicity, obesity, insulin use, or molecular structure of GLP-1 agonist agent ...

Dr Almandoz discusses the important considerations for women with obesity who are using GLP-1 therapies and may be considering pregnancy or are currently pregnant. The clip highlights the ...

Research shows that people on GLP-1 medications are ditching processed foods and buying more nutrient-dense ones like fresh produce, beans and yogurt. (Photo illustrations: Yahoo News; photos ...

In recent years, the growing list of medical benefits for GIP and GLP-1 agonists (think Ozempic for diabetes or Zepbound for weight loss, among others) has caused demand to skyrocket ...

ACCESS and ACCESS II studies fully enrolled; topline data from both studies anticipated by year-end 2025Oral small ...